DYADIC INTERNATIONAL
1.9100
25-نوفمبر-24 16:45:01
15 متأخرة بدقائق
الأسهم
-0.0200
-1.04%
نطاق اليوم
1.7900 - 2.0000
ISIN
N/A
المصدر
NASDAQ
-
Dyadic to Report 2021 Year-End Financial Results on Tuesday, March 29, 2022
15 مارس 2022 16:30:00 بحسب Nasdaq GlobeNewswire
-
10 فبراير 2022 08:30:00 بحسب Nasdaq GlobeNewswire
-
Dyadic International’s CEO Mark Emalfarb to Present at BIO CEO & Investor Conference
07 فبراير 2022 08:30:01 بحسب Nasdaq GlobeNewswire
-
20 يناير 2022 08:30:00 بحسب Nasdaq GlobeNewswire
-
Dyadic Announces a NIIMBL Coronavirus Grant Under the White House’s American Rescue Plan
22 ديسمبر 2021 09:12:47 بحسب Nasdaq GlobeNewswire
-
17 ديسمبر 2021 07:00:00 بحسب Nasdaq GlobeNewswire
-
Dyadic Reports Third Quarter 2021 Financial Results and Highlights Recent Company Progress
10 نوفمبر 2021 16:00:00 بحسب Nasdaq GlobeNewswire
-
Dyadic Appoints Chief Business Officer to Executive Leadership Team
09 نوفمبر 2021 08:30:00 بحسب Nasdaq GlobeNewswire
-
Dyadic to Report Third Quarter 2021 Financial Results on Wednesday, November 10, 2021
27 أكتوبر 2021 16:30:00 بحسب Nasdaq GlobeNewswire
-
Dyadic to Present at H.C. Wainwright 23rd Annual Global Investment Conference
10 سبتمبر 2021 08:30:00 بحسب Nasdaq GlobeNewswire
-
11 أغسطس 2021 08:35:40 بحسب Nasdaq GlobeNewswire
-
27 يوليو 2021 08:20:00 بحسب Nasdaq GlobeNewswire
-
28 يونيو 2021 08:30:00 بحسب Nasdaq GlobeNewswire
-
Dyadic announces development of COVID-19 Vaccine in India
26 مايو 2021 08:30:01 بحسب Nasdaq GlobeNewswire
-
Dyadic to Present at Upcoming Events
03 مايو 2021 08:30:00 بحسب Nasdaq GlobeNewswire
-
22 أبريل 2021 08:30:01 بحسب Nasdaq GlobeNewswire
-
29 مارس 2021 08:30:00 بحسب Nasdaq GlobeNewswire
-
Dyadic and Medytox To Develop Vaccines Against COVID-19 Variants
23 مارس 2021 09:00:01 بحسب Nasdaq GlobeNewswire
-
Dyadic and Medytox To Develop Vaccines Against COVID-19 Variants
22 مارس 2021 21:00:00 بحسب Nasdaq GlobeNewswire
-
Dyadic and Medytox To Develop Vaccines Against COVID-19 Variants
22 مارس 2021 08:30:00 بحسب Nasdaq GlobeNewswire